Shenzhen Glory Medical Co.,Ltd.
符号: 002551.SZ
SHZ
3.25
CNY今天的市场价格
-16.6251
市盈率
0.6657
PEG比率
2.75B
MRK市值
- 0.00%
DIV收益率
Shenzhen Glory Medical Co.,Ltd. (002551-SZ) 财务报表
资产负债表
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 3585.05 | 818.2 | 920.1 | 1088.9 | |||||||||||||||||
balance-sheet.row.short-term-investments | 1239.9 | 327.9 | 434.9 | 292.5 | |||||||||||||||||
balance-sheet.row.net-receivables | 2831.97 | 611 | 653.9 | 871.2 | |||||||||||||||||
balance-sheet.row.inventory | 1558.23 | 371.5 | 416.8 | 375.9 | |||||||||||||||||
balance-sheet.row.other-current-assets | 409.81 | 21.9 | 37.4 | 57.4 | |||||||||||||||||
balance-sheet.row.total-current-assets | 8137.23 | 1822.7 | 2028.2 | 2393.4 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 2001.82 | 488.8 | 556 | 637.6 | |||||||||||||||||
balance-sheet.row.goodwill | 27.57 | 1.4 | 12.4 | 68.6 | |||||||||||||||||
balance-sheet.row.intangible-assets | 1099.93 | 280.4 | 510 | 275.6 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 1127.5 | 281.8 | 522.4 | 344.2 | |||||||||||||||||
balance-sheet.row.long-term-investments | -434.24 | -194.7 | -288.1 | 90.1 | |||||||||||||||||
balance-sheet.row.tax-assets | 356.29 | 103.9 | 137.4 | 93.1 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 5026.85 | 1429.3 | 1304.6 | 1414.8 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 8078.22 | 2109.1 | 2232.3 | 2579.8 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 16215.46 | 3931.7 | 4260.5 | 4973.2 | |||||||||||||||||
balance-sheet.row.account-payables | 1419.65 | 381.9 | 380 | 447.1 | |||||||||||||||||
balance-sheet.row.short-term-debt | 71.74 | 21.1 | 41.5 | 61.1 | |||||||||||||||||
balance-sheet.row.tax-payables | 235.77 | 73.8 | 81.2 | 97.8 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 1106.62 | 269.5 | 290.6 | 331.1 | |||||||||||||||||
Deferred Revenue Non Current | 244.94 | 80.4 | 84.3 | 75 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0.67 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 515.54 | 24.2 | 237.1 | 7.5 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 1443.15 | 354.2 | 379 | 417.4 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-liab | 4829.33 | 1184 | 1261.2 | 1526.8 | |||||||||||||||||
balance-sheet.row.preferred-stock | 126.64 | 59.5 | 65.2 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 3379.16 | 844.8 | 844.8 | 844.7 | |||||||||||||||||
balance-sheet.row.retained-earnings | 2105.02 | 429.8 | 578.7 | 829.7 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 1074.15 | -59.5 | -65.2 | 42.5 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 4092.28 | 1339.6 | 1333.6 | 1403.8 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 10777.25 | 2614.2 | 2757.1 | 3120.7 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 16215.46 | 3931.7 | 4260.5 | 4973.2 | |||||||||||||||||
balance-sheet.row.minority-interest | 608.88 | 133.6 | 242.2 | 325.7 | |||||||||||||||||
balance-sheet.row.total-equity | 11386.13 | 2747.8 | 2999.3 | 3446.4 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 16215.46 | - | - | - | |||||||||||||||||
Total Investments | 805.66 | 133.1 | 146.8 | 382.6 | |||||||||||||||||
balance-sheet.row.total-debt | 1178.36 | 290.6 | 332.1 | 392.2 | |||||||||||||||||
balance-sheet.row.net-debt | -1166.79 | -199.7 | -153.2 | -404.2 |
现金流量表
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -142.04 | -327.9 | 88 | 369.9 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | 37.4 | 125 | 76.7 | 55.1 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -44.4 | -1.2 | -1.1 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 44.4 | 1.2 | 1.1 | ||||||||||||||||
cash-flows.row.change-in-working-capital | 37.9 | -90.4 | 57.9 | 30.6 | ||||||||||||||||
cash-flows.row.account-receivables | 29.17 | 156.3 | 49.6 | 116.2 | ||||||||||||||||
cash-flows.row.inventory | 8.73 | -55.9 | -38.6 | -41 | ||||||||||||||||
cash-flows.row.account-payables | 0 | -146.4 | 48.1 | -43.5 | ||||||||||||||||
cash-flows.row.other-working-capital | 0 | -44.4 | -1.2 | -1.1 | ||||||||||||||||
cash-flows.row.other-non-cash-items | -8.88 | 389.7 | 20 | 41.9 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -162.73 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -48.06 | -57.3 | -430 | -254.2 | ||||||||||||||||
cash-flows.row.acquisitions-net | 1.23 | 1.5 | 0.5 | -67.1 | ||||||||||||||||
cash-flows.row.purchases-of-investments | -814.88 | -865.4 | -1221 | -295.2 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 863.05 | 732.6 | 1087.2 | 473.3 | ||||||||||||||||
cash-flows.row.other-investing-activites | 84.27 | 11.7 | -0.1 | -5.4 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 85.43 | -176.8 | -563.4 | -148.6 | ||||||||||||||||
cash-flows.row.debt-repayment | -103.35 | -88.8 | -248.4 | -204.2 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0.19 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | -0.19 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.dividends-paid | -57.3 | -164 | -30.3 | -49.8 | ||||||||||||||||
cash-flows.row.other-financing-activites | 52.56 | 61.7 | 287 | 338.9 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -45.97 | -191.1 | 8.3 | 84.9 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -8.8 | 6.1 | 4.7 | -20.3 | ||||||||||||||||
cash-flows.row.net-change-in-cash | -132.06 | -265.4 | -307.7 | 413.6 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 1983.54 | 387.2 | 652.6 | 960.4 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 2115.6 | 652.6 | 960.4 | 546.8 | ||||||||||||||||
cash-flows.row.operating-cash-flow | -162.73 | 96.5 | 242.6 | 497.5 | ||||||||||||||||
cash-flows.row.capital-expenditure | -48.06 | -57.3 | -430 | -254.2 | ||||||||||||||||
cash-flows.row.free-cash-flow | -210.79 | 39.2 | -187.4 | 243.3 |
利润表行
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1159.63 | 1192.9 | 1275.7 | 1790.3 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 972.72 | 995.3 | 1053.8 | 1427.4 | |||||||||||||||||
income-statement-row.row.gross-profit | 186.91 | 197.6 | 221.9 | 362.9 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 40.19 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 35.16 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 18.79 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | -6.91 | -6.4 | 115.4 | 100.6 | |||||||||||||||||
income-statement-row.row.operating-expenses | 187.94 | 217.5 | 228.4 | 267.9 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 1160.66 | 1212.8 | 1282.3 | 1695.3 | |||||||||||||||||
income-statement-row.row.interest-income | 11.44 | 8.7 | 6.9 | 5.2 | |||||||||||||||||
income-statement-row.row.interest-expense | 1.74 | 2 | 4.4 | 7.2 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 18.79 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 13.28 | -6.4 | -385.2 | -37.7 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | -6.91 | -6.4 | 115.4 | 100.6 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | 13.28 | -6.4 | -385.2 | -37.7 | |||||||||||||||||
income-statement-row.row.interest-expense | 1.74 | 2 | 4.4 | 7.2 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 141.73 | 95.9 | 125 | 76.7 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 14.82 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | -126.91 | -121.2 | 0.8 | 126.7 | |||||||||||||||||
income-statement-row.row.income-before-tax | -113.63 | -127.6 | -384.4 | 89.1 | |||||||||||||||||
income-statement-row.row.income-tax-expense | 36.6 | 33.2 | -56.5 | 1 | |||||||||||||||||
income-statement-row.row.net-income | -142.04 | -148.9 | -327.9 | 88 |
常见问题
什么是 Shenzhen Glory Medical Co.,Ltd. (002551.SZ) 总资产是多少?
Shenzhen Glory Medical Co.,Ltd. (002551.SZ) 总资产为 3931719261.000.
什么是企业年收入?
年收入为 550234370.000.
企业利润率是多少?
公司利润率为 0.166.
什么是公司自由现金流?
自由现金流为 -0.299.
什么是企业净利润率?
净利润率为 -0.125.
企业总收入是多少?
总收入为 -0.102.
什么是 Shenzhen Glory Medical Co.,Ltd. (002551.SZ) 净利润?{{符号}}净利润(净收入)是多少?
净利润(净收入)为 -148889156.240.
公司总债务是多少?
债务总额为 290603679.000.
营业费用是多少?
运营支出为 217491767.000.
公司现金是多少?
企业现金为 616750849.000.